We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's lead program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP... Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's lead program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). Show more
Savaraβs Partner, Trillium Health LLC, to Present Data on the Laboratory Blood Test for Diagnosing aPAP Company to Host Industry Theater on Pulmonary Alveolar Proteinosis (PAP) with Two...
Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the grant of inducement awards to two new employees. On March 21...
Remains On-Track to Report Top Line Data from the Pivotal Phase 3 IMPALA-2 Trial by End of 2Q 2024 48-week placebo-controlled trial is evaluating molgramostim nebulizer solution (molgramostim...
Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that its management team will participate in a fireside chat at the...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.19 | 3.98322851153 | 4.77 | 5.34 | 4.77 | 1782790 | 5.11065395 | CS |
4 | 0.04 | 0.813008130081 | 4.92 | 5.34 | 4.5201 | 821744 | 4.9868885 | CS |
12 | -0.08 | -1.5873015873 | 5.04 | 5.7 | 4.52 | 842941 | 5.00937883 | CS |
26 | 1.51 | 43.768115942 | 3.45 | 5.7 | 3.115 | 812506 | 4.59409235 | CS |
52 | 3.2 | 181.818181818 | 1.76 | 5.7 | 1.72 | 664858 | 4.06281913 | CS |
156 | 3.17 | 177.094972067 | 1.79 | 5.7 | 1.02 | 459786 | 2.78902255 | CS |
260 | -4 | -44.6428571429 | 8.96 | 11.96 | 0.69 | 688408 | 2.7044003 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions